Recently, Jones and collaborators [32] reported high levels of glycogen synthase kinase-3 beta (GSK3β) in skeletal muscle from DM1 patients that cause a reduction of cyclin D3 expression. Here, GSK3B is linked to myotonic dystrophy type 1.